The vitamin C family is one of the most extensively studied groups of brightening actives in cosmetic science. Glabridin and vitamin C derivatives influence melanogenesis through partially distinct but overlapping biological pathways, with formulation-dependent complementary functions. The key formulation decision — selecting the appropriate vitamin C derivative and evaluating its compatibility with glabridin — depends not only on pH requirements, but also on system stability, redox environment, and overall formulation design.
The Vitamin C Family: Not All Are Equal
"Vitamin C" in cosmetic formulation refers to multiple structurally distinct compounds with different stability profiles, delivery characteristics, and formulation requirements.
| Form | INCI Name | Solubility | Stability | Optimal pH | Bioactivity |
|---|---|---|---|---|---|
| L-Ascorbic Acid (LAA) | Ascorbic Acid | Water | Poor — oxidizes rapidly | 2.5–3.5 | High (direct) |
| Ascorbyl Glucoside (AA-2G) | Ascorbyl Glucoside | Water | Excellent | 5.0–7.0 | High (enzymatic conversion in skin) |
| Magnesium Ascorbyl Phosphate (MAP) | Magnesium Ascorbyl Phosphate | Water | Good | 5.5–7.0 | High (enzymatic conversion in skin) |
| Sodium Ascorbyl Phosphate (SAP) | Sodium Ascorbyl Phosphate | Water | Good | 5.5–7.5 | Moderate |
| Ascorbyl Palmitate | Ascorbyl Palmitate | Oil | Moderate | 4.5–6.5 | Low (primarily antioxidant; limited conversion) |
| Tetrahexyldecyl Ascorbate (THDC) | Tetrahexyldecyl Ascorbate | Oil | Good | 4.5–6.5 | High (lipophilic derivative with in-skin conversion; not direct activity) |
| Ethyl Ascorbic Acid (3-O-EAA) | 3-O-Ethyl Ascorbic Acid | Water/alcohol | Good | 4.0–6.5 | High |
For the purpose of comparing with glabridin, the most important distinction is between raw L-ascorbic acid, which requires a low-pH environment incompatible with glabridin, and stable vitamin C derivatives, which operate within a broader pH window and are generally more compatible in formulation systems.
Mechanism: Where Each Acts
Glabridin — Inhibits Melanin Production (Upstream)
Glabridin inhibits tyrosinase activity and has been shown in vitro to reduce the enzyme's catalytic efficiency, with kinetic studies suggesting a non-competitive inhibition pattern. In addition, glabridin suppresses inflammation-related signaling pathways such as COX and PGE₂, which are involved in UV- and stress-induced melanogenesis. Overall, glabridin acts primarily at early stages of melanin formation and its regulatory signaling pathways (Yokota et al., 1998).
Vitamin C — Acts on Melanin Synthesis Intermediates (Downstream)
Vitamin C's brightening activity involves the reduction of dopaquinone back to DOPA, influencing the melanin synthesis cascade downstream of tyrosinase activity. Dopaquinone is an oxidized intermediate in the melanin pathway — vitamin C reduces it, thereby modulating the progression toward dark eumelanin pigment formation.
Additionally, vitamin C contributes antioxidant protection against UV-triggered reactive oxygen species (ROS), which would otherwise stimulate melanogenesis.
The key mechanistic distinction: glabridin inhibits melanin production by regulating melanogenesis-related pathways; vitamin C modulates melanogenesis by reducing oxidized melanin intermediates formed during the synthesis process. They address different stages within the same pathway.
The pH Compatibility Map
This is the most practically important section for formulators. The pH compatibility between glabridin and different vitamin C forms determines which combinations are viable.
| Vitamin C Form | Optimal pH | Compatible with Glabridin? | Notes |
|---|---|---|---|
| L-Ascorbic Acid | 2.5–3.5 | ❌ No — direct pH incompatibility | pH required for LAA is below glabridin's safe floor (4.0). In a single formulation, maintaining optimal conditions for both actives is difficult due to conflicting pH requirements. |
| Ascorbyl Glucoside (AA-2G) | 5.0–7.0 | ✅ Yes — pH 5.0–6.0 | Full overlap with glabridin's pH window. Recommended stable Vitamin C partner. |
| Magnesium Ascorbyl Phosphate (MAP) | 5.5–7.0 | ✅ Yes — pH 5.5–6.0 | Overlap at upper edge of glabridin's acceptable range. Viable with close pH management. |
| Sodium Ascorbyl Phosphate (SAP) | 5.5–7.5 | ✅ Yes — pH 5.5–6.5 | Overlap at glabridin's acceptable upper range. Workable with pH control. |
| Ascorbyl Palmitate | 4.5–6.5 | ✅ Yes — pH 4.5–6.5 | Oil-soluble; can share the oil phase with glabridin; compatible pH range. |
| Tetrahexyldecyl Ascorbate (THDC) | 4.5–6.5 | ✅ Yes — pH 4.5–6.5 | Oil-soluble; premium stable form; compatible with glabridin in oil or anhydrous phase. |
| 3-O-Ethyl Ascorbic Acid | 4.0–6.5 | ✅ Yes — pH 4.0–6.0 | Good overlap; water/alcohol soluble; viable partner. |
Stable vitamin C derivatives with a pH optimum at or above 5.0 generally offer better compatibility potential with glabridin in formulation systems. However, compatibility is not determined by pH alone but also depends on overall formulation stability, redox environment, and system design. Raw L-ascorbic acid presents a significant formulation incompatibility due to its low-pH requirement.
Why Raw L-Ascorbic Acid and Glabridin Cannot Be Combined
This is worth stating explicitly because the combination is occasionally attempted in practice.
L-Ascorbic acid requires pH 2.5–3.5 to remain stable and bioactive. At pH above 4.0, LAA undergoes rapid oxidative degradation, converting to dehydroascorbic acid and subsequently to diketogulonic acid, resulting in loss of both stability and efficacy over time.
Glabridin requires a pH range of approximately 4.0–6.5 to remain stable. Below pH 4.0, glabridin may still exhibit short-term stability, but long-term stability becomes less favorable. At the pH required for LAA (2.5–3.5), the highly acidic environment combined with the oxidative conditions (LAA degradation may contribute to an oxidative environment) may increase formulation instability risk for glabridin over time.
More fundamentally, there is no single aqueous pH condition where both LAA and glabridin can simultaneously achieve their respective optimal stability ranges over a commercially relevant shelf life. A pH of 3.5 is near the upper stability limit of LAA and near the lower boundary of glabridin's preferred range. Even at this compromise value, LAA stability would still be limited and glabridin would be under suboptimal stability conditions, which may lead to gradual degradation of both actives during storage.
Practical conclusion: Stable vitamin C derivatives are generally preferred over raw L-ascorbic acid in glabridin-containing formulations.
Stability Comparison
Beyond the pH issue, glabridin and the vitamin C family have parallel but distinct stability challenges.
| Stability Factor | Glabridin | Stable Vitamin C Derivatives (AA-2G, MAP) | Raw L-Ascorbic Acid |
|---|---|---|---|
| Primary degradation route | Oxidation of phenolic hydroxyl groups | Hydrolytic and oxidative degradation (depending on derivative structure) | Direct oxidation to dehydroascorbic acid |
| Color development on degradation | Formula yellowing | Potential slight yellowing (system-dependent, e.g. MAP/SAP) | Brown discoloration |
| Rate of degradation | Moderate (manageable with antioxidant + chelation + pH control) | Generally slower than LAA under comparable conditions | Rapid above pH 4.0 |
| Chelator requirement | Yes (EDTA or sodium phytate) | Beneficial but less critical | Required at higher levels |
| Photostability | Moderate | Good | Poor |
| Packaging requirement | Airless + UV-blocking | UV-protective recommended | Airtight + opaque essential |
Both glabridin and stable vitamin C derivatives require antioxidant protection and good packaging. The key difference: stable derivatives are generally more compatible with formulation requirements and offer greater pH flexibility, and do not impose the extreme pH constraint that significantly limits the compatibility of L-ascorbic acid with glabridin in aqueous systems.
Recommended Combinations
For Water-Based Systems (Toners, Essences, Aqueous Serums)
| Grade | Recommended Vitamin C Partner | Target pH | Notes |
|---|---|---|---|
| 10% water-soluble glabridin (HP-β-CD) | AA-2G at 1–3% | 5.0–5.5 | Both water-soluble; fully compatible in aqueous phase |
| 10% water-soluble glabridin (HP-β-CD) | 3-O-Ethyl Ascorbic Acid at 1–3% | 4.5–5.5 | Good overlap; ethyl ascorbic acid provides better intrinsic stability in aqueous systems |
For Emulsions (O/W Creams and Serums)
| Grade | Recommended Vitamin C Partner | Phase | Target pH | Notes |
|---|---|---|---|---|
| 40%/90%/98% glabridin (polyol phase) | AA-2G (water phase) | Separate phases | 5.0–5.5 | Standard O/W approach; each active in its compatible phase |
| 90% oil-soluble glabridin (oil phase, 0.2%) | THDC or ascorbyl palmitate (oil phase) | Oil phase (lipophilic system) | 4.5–6.0 | Oil-phase brightening system; suitable for anhydrous or oil-dominant systems |
For Face Oils and Anhydrous Systems
| Grade | Recommended Vitamin C Partner | Notes |
|---|---|---|
| 90% oil-soluble glabridin (0.2%) | Tetrahexyldecyl Ascorbate (THDC) or Ascorbyl Palmitate | Both oil-soluble; can share the oil phase; complementary mechanisms within the same phase |
THDC is the preferred oil-soluble vitamin C for face oil applications: high stability, good skin penetration potential, and well-documented brightening activity in cosmetic formulations.
Efficacy Perspective: Production Inhibition + Reduction = Comprehensive Brightening Effect
The combined mechanism of glabridin (upstream synthesis inhibition) and stable vitamin C (downstream reduction of melanin intermediates) addresses both the production and the partial modulation of pigmentation in a single system.
This is particularly relevant for:
- Active hyperpigmentation where existing pigment needs to be addressed while preventing new production
- Post-inflammatory hyperpigmentation, where glabridin's anti-inflammatory activity (including COX pathway inhibition) addresses the inflammatory origin, while vitamin C's antioxidant activity helps mitigate ROS-related melanogenesis signaling
- UV-induced pigmentation, where vitamin C's antioxidant contribution against UV-generated ROS complements glabridin's tyrosinase inhibition
Every batch ships with COA, TDS, and SDS/MSDS. Additional testing available upon request.
References
- Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Research, 11(6), 355–361, 1998. DOI: 10.1111/j.1600-0749.1998.tb00494.x.
- Nerya O, Vaya J, Musa R, Izrael S, Ben-Arie R, Tamir S. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. Journal of Agricultural and Food Chemistry, 51(5), 1201–1207, 2003. — IC₅₀ comparative data including Vitamin C, under comparable in vitro assay conditions.
- Ao M, Shi Y, Cui Y, Guo W, Wang J, Yu L. Factors influencing glabridin stability. Natural Product Communications, Vol. 5(12), 1907–1912, 2010. DOI: 10.1177/1934578X1000501214. PMID: 21299118.
- Guangdong Weipu Testing Technology Co., Ltd. (CMA No. 202119135666). Report No. GZA01-23080632-JC-01. Human skin brightening efficacy study, 0.03% Glabridin. Commissioned by Huatai Bio-Fine Chemical.
English
German
Italian
French
Spanish
Japanese
Korean
Russian